Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

The Cardiovascular Market Outlook to 2017 Published on June 2012

Report Summary This report covers antihypertensives, antidyslipidemics, and antithrombotics, which are the three leading categories of cardiovascular therapies by sales. Current and forecast sales of leading established brands in these categories are provided. Growth brands, key drug classes, and leading players through to 2017 are identified. Major pipeline products are profiled including estimated filing year.Identify growth brands, key drug classes, and leading players through to 2017.Review sales forecasts to 2017 for leading products, with analysis of key growth drivers and resistors across the seven major pharmaceutical markets.Evaluate the commercial impact of recently completed and ongoing clinical trials.Assess the target populations, market potential, and forecast approval dates of major pipeline products.Understand the present unmet needs, treatment guidelines, and the epidemiology of cardiovascular disease.Antihypertensives are the largest drug category within the cardiovascular market by sales, but this category will undergo significant value erosion by 2017, principally due to increasing generic competition in the angiotensin receptor blockers class, which accounted for 70% of total antihypertensive sales in 2011The value of the antidyslipidemic class will fall to around $8.2bn in 2017, partly due to the loss of exclusivity of Lipitor, previously the world's best-selling drug. The availability of generic atorvastatin will halt Crestor sales growth up to loss of exclusivity.Novel oral anticoagulants are likely to be the fastest growing class of antithrombotics over the forecast period, driven by sales of Boehringer Ingelheim's Pradaxa, Bayer's Xarelto, and Pfizer/Bristol-Myers Squibb's Eliquis.How does the market outlook vary for the antihypertensives, antidyslipidemics, and antithrombotics categories up to 2017'What are the key growth brands'Which were the most important companies in the cardiovascular market in 2011'How will the loss of exclusivity of leading brands shape the cardiovascular market, and can pipeline products compensate for these lost sales'Which novel therapeutics offer significant potential for future growth'

The Cardiovascular Market Outlook to 2017 (From Issuu)

Page 1/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. The Cardiovascular Market Outlook to 2017

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 835.00

Quantity: _____

Corporate License--USD 9 587.50

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

The Cardiovascular Market Outlook to 2017 (From Issuu)

Page 2/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

The Cardiovascular Market Outlook to 2017 (From Issuu)

Asia, Oceania and America : + 1 (805) 617 17 93

Page 3/3


The Cardiovascular Market Outlook to 2017